Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
8
×
Tags
medicare
8
×
national blog main
san francisco blog main
san francisco top stories
biotech
boston blog main
boston top stories
cancer immunotherapy
deals
life sciences
national
national top stories
new york blog main
new york top stories
startups
wisconsin blog main
wisconsin top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
eli lilly
indiana blog main
indiana top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
aduro biotech
affordable care act
alzheimer's disease
biogen
celgene
drug prices
What
companies
8
×
bio
new
roundup
alzheimer’s
drug
earlier
healthcare
ipo
life
market
price
raise
science
therapies
week
achieving
acquired
align
america
analytics
apple
appleton
approval
arena’s
arrival
attention
based
better
betterdoctor
biggest
biogen’s
biopharmaceutical
biotech
boast
boon
bounty
built
business
buys
Language
unset
Current search:
medicare
×
companies
×
photo
×
@xconomy.com
4 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@techcrunch.com
5 years ago
Why you should naturalize — now, not later
@techcrunch.com
5 years ago
As Alzheimer’s costs soar, startups like Neurotrack raise cash to diagnose and treat the disease
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Fail, Drug Price Plan, Gene Therapies & More
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
@xconomy.com
6 years ago
Quest Analytics Buys Healthcare Compliance Software Firm BetterDoctor
@techcrunch.com
8 years ago
Fee-For-Value Drives Trillion-Dollar Healthcare Opportunity